Thermo Fisher Targets Indian CRO, Generic Drug Market with LC, MS Software Alliance | GenomeWeb
This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
 
Recognizing the growing number of generic drug studies being conducted in India and the proliferation of contract research organizations in that country, Thermo Fisher Scientific this week announced that it is collaborating with Megaware to provide an automated software solution for bioequivalence studies.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.